Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients

Elisna Syahruddin, - and Laksmi Wulandari, - and Nunuk Sri Muktiati, - and Ana Rima, - and Noni Soeroso, - and Sabrina Ermayanti, - and Michael Levi, - and Heriawaty Hidajat, - and Grace Widjajahakim, - and Ahmad Rusdan Handoyo Utomo, - (2018) Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients. Lung Cancer: Targets and Therapy, 2018 (9). pp. 25-34. ISSN 11792728

[img] Text (Peer Review)
1. Karil_4.pdf

Download (361kB)
[img] Text (Similarity)
2. Turnitin_4.PDF

Download (2MB)
[img] Text (Artikel)
3. Fulltext_4.pdf

Download (3MB)
Official URL: https://www.dovepress.com/uncommon-egfr-mutations-...

Abstract

Purpose: We aimed to evaluate the distribution of individual epidermal growth factor receptor (EGFR) mutation subtypes found in routine cytological specimens. Patients and methods: A retrospective audit was performed on EGFR testing results of 1,874 consecutive cytological samples of newly diagnosed or treatment-naïve Indonesian lung cancer patients (years 2015–2016). Testing was performed by ISO15189 accredited central laboratory. Results: Overall test failure rate was 5.1%, with the highest failure (7.1%) observed in pleural effusion and lowest (1.6%) in needle aspiration samples. EGFR mutation frequency was 44.4%. Tyrosine kinase inhibitor (TKI)-sensitive common EGFR mutations (ins/dels exon 19, L858R) and uncommon mutations (G719X, T790M, L861Q) contributed 57.1% and 29%, respectively. Approximately 13.9% of mutation-positive patients carried a mixture of common and uncommon mutations. Women had higher EGFR mutation rate (52.9%) vs men (39.1%; p<0.05). In contrast, uncommon mutations conferring either TKI responsive (G719X, L861Q) or TKI resistance (T790M, exon 20 insertions) were consistently more frequent in men than in women (67.3% vs 32.7% or 69.4% vs 30.6%; p<0.05). Up to 10% EGFR mutation–positive patients had baseline single mutation T790M, exon 20 insertion, or in coexistence with TKI-sensitive mutations. Up to 9% patients had complex or multiple EGFR mutations, whereby 48.7% patients harbored TKI-resistant mutations. One patient presented third-generation TKI-resistant mutation L792F simultaneously with T790M. Conclusion: Routine diagnostic cytological techniques yielded similar success rate to detect EGFR mutations. Uncommon EGFR mutations were frequent events in Indonesian lung cancer patients.

Item Type: Article
Uncontrolled Keywords: EGFR mutations, lung cancer, treatment naive, T790M, tyrosine kinase inhibitor, Indonesia, cytology
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Divisions: 01. Fakultas Kedokteran > Ilmu Pulmonologi dan Ilmu kedokteran Respirasi
Creators:
CreatorsNIM
Elisna Syahruddin, -UNSPECIFIED
Laksmi Wulandari, -NIDN8878210016
Nunuk Sri Muktiati, -UNSPECIFIED
Ana Rima, -UNSPECIFIED
Noni Soeroso, -UNSPECIFIED
Sabrina Ermayanti, -UNSPECIFIED
Michael Levi, -UNSPECIFIED
Heriawaty Hidajat, -UNSPECIFIED
Grace Widjajahakim, -UNSPECIFIED
Ahmad Rusdan Handoyo Utomo, -UNSPECIFIED
Depositing User: arys fk
Date Deposited: 23 Oct 2022 23:03
Last Modified: 23 Oct 2022 23:03
URI: http://repository.unair.ac.id/id/eprint/118345
Sosial Share:

Actions (login required)

View Item View Item